KRRO

KORRO BIO INC

KRRO·500946108·US·Common Stock·Healthcare - Biotechnology-Activist

KRRO (KORRO BIO INC) is held by 56 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($11.8M), BlackRock, Inc. ($5.2M), DRIEHAUS CAPITAL MANAGEMENT LLC ($5.1M). Net institutional sentiment: Mixed.

56
Holders
Avg rating(14 Elite)
$50.4M
Total Value
58% (67)
Fund Consensus
37 buying - 27 selling
KRROSmart Money Verdict
View all
Held by 56 funds
14 elite
Who's Trading
InsiderARAiyar RamSell $197KMay 29, 2026
ActivistBalyasny Asset Management L.P.Balyasny Asset Management L.P.7.2%May 15, 2026
ActivistLYLynx1 Capital Management LP10.7%Apr 2, 2026
InsiderLLLynx1 Capital Management LPBuy $6KMar 31, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.9%Mar 17, 2026
ActivistNENew Enterprise Associates 17, L.P.9.9%Mar 12, 2026
InsiderMMMakhzoumi MohamadBuy $2.3MMar 10, 2026
InsiderWEWalker Paul EdwardBuy $2.3MMar 10, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1M$11.8M0.0%+35.44%
39
Increased
460,006(+0.6%)$5.2M0.0%-59.70%
27
New
450,045$5.1M0.0%+35.44%
37
New
310,913$3.5M0.0%+35.44%
37
Increased
267,755(+558.7%)$3M0.0%-6.76%
43
New
228,400$2.6M0.0%+35.44%
36
Increased
173,643(+6.7%)$2M0.0%-58.91%
28
Increased
165,472(+109.5%)$1.9M0.0%-9.85%
42
New
148,559$1.7M0.0%+35.44%
36
Decreased
140,341(-4.0%)$1.6M0.0%-59.17%
0
Increased
136,227(+81.9%)$1.5M0.0%+39.90%
39
Decreased
115,704(-59.9%)$1.3M0.0%+84.30%
0
Decreased
63,606(-60.5%)$720,0200.0%-55.25%
0
Increased
68,500(+2313.7%)$704,1800.0%+20.60%
27
Increased
60,472(+6.0%)$684,5430.0%-56.13%
26
Increased
57,702(+3.7%)$653,1860.0%-59.52%
25
New
56,208$636,2750.0%+35.44%
34
Decreased
50,541(-2.7%)$572,1240.0%-21.02%
0
Increased
42,838(+86.0%)$484,9260.0%-26.64%
37
New
41,541$470,2440.0%+35.44%
33

Showing 1-20 of 67

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used